News

Filter

Current filters:

trastuzumab

1 to 9 of 316 results

Benefits of Herceptin outweigh the risk of harm in advanced breast cancer

Benefits of Herceptin outweigh the risk of harm in advanced breast cancer

12-06-2014

In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug trastuzumab,…

HerceptinOncologyPharmaceuticalResearchRochetrastuzumab

ASCO 2014: latest news on lapatinib and trastuzumab, and ibrutinib

ASCO 2014: latest news on lapatinib and trastuzumab, and ibrutinib

01-06-2014

There was more important news on investigational oncology products presented at the 2014 Annual Meeting…

BiotechnologyGlaxoSmithKlineibrutinibJanssen BiotechJohnson & JohnsonLapatinibOncologyPharmacyclicsResearchtrastuzumab

Biocon introduces biosimilar trastuzumab for breast cancer in India

20-01-2014

India-based biotech firm Biocon (BSE: 532523) has introduced Canmab, a biosimilar trastuzumab, for the…

BioconBiosimilarsIndiaMarkets & MarketingOncologytrastuzumab

Study confirms everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer

03-05-2013

A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast…

AfinitoreverolimusHerceptinNovartisOncologyPharmaceuticalResearchRochetrastuzumab

Roche to file for trastuzumab emtansine this year, on positive Ph III results

03-04-2012

Swiss drug major Roche (ROG: SIX) says that top-line results of EMILIA, the first randomized Phase III…

BiotechnologyGenentechGlaxoSmithKlineOncologyPharmaceuticalRegulationResearchRochetrastuzumab

GlaxoSmithKline files for Tykerb/Tyverb with trastuzumab in USA and Europe

17-02-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday that it has submitted regulatory applications…

EuropeGlaxoSmithKlineNorth AmericaOncologyPharmaceuticalRegulationtrastuzumabTykerbTyverb

Glycotope enrolls first patient for “biobetter” of Roche cancer drug Herceptin

20-09-2011

Berlin, Germany-based glycomics specialist Glycotope GmbH says it has enrolled the first patients in…

BiotechnologyGenericsGlycotopeHerceptinOncologyResearchRochetrastuzumab

1 to 9 of 316 results

COMPANY SPOTLIGHT

Menarini

Back to top